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ABSTRACT
The aim of this study was to demonstrate the non-
inferiority of a novel teat disinfectant based on copper 
and zinc (ZkinCu; Copper Andino, Santiago de Chile, 
Chile) compared with a previously proven glycolic acid 
active disinfectant (OceanBlu; DeLaval, Kansas City, 
MO) as a positive control, with respect to the inci-
dence of new intramammary infections under natural 
challenge conditions on a commercial robotic dairy 
farm. This study was conducted in 6 robotic pens of 
approximately 60 milking cows each. The pens were 
randomly assigned to 1 of the 2 studied disinfectants. 
Throughout the 8 wk study, the same pre- and post-
milking teat disinfectant was used in each pen. The 
same milking procedures were used in each robot 
throughout the study. Pre-milking hygiene consisted of 
applying the disinfectant (OceanBlu or ZkinCu) with 
the robotic arm. The same product was applied on the 
teats after milking. At the beginning of the study, all 
quarters of all study cows were sampled. In successive 
samplings (wk 2, 4, 6, and 8), composite milk samples 
were collected on farm to determine SCC. Once com-
posite SCC results were available (2 d) and based on 
an SCC of ≥100,000 cells/mL, quarter milk samples 
underwent bacteriological culture. Clinical mastitis was 
identified by study personnel. Intramammary infection 
in biweekly quarter milk samples was determined based 
on composite SCC levels (≥100,000 cells/mL) and 
the presence of bacteria. A new IMI was defined as a 
quarter in which the organism isolated was not present 
in the previous bacteriological sample, or the previous 
composite SCC sample was <100,000 cells/mL. Clini-
cal mastitis samples were also considered to be new 
IMI. The trial was designed as a positive control field 
trial, in which the objective was to show noninferiority 
of ZkinCu versus the control (OceanBlu). The overall 
crude incidences of new IMI for 2 wk at risk were 4.9 
and 7.3% for the ZkinCu and OceanBlu groups, re-
spectively. The predominant organisms recovered from 
quarters with new IMI were Streptococcus uberis, Cory-
nebacterium spp., and coagulase-negative staphylococci 
in both the ZkinCu and OceanBlu groups. The risk of 
infection in the OceanBlu group was higher (β = 0.644; 
95% confidence interval = 0.05–1.22). The interaction 
of treatment by week was not significant. The new IMI 
rate estimates (95% confidence interval) for ZkinCu 
and OceanBlu were 1.7% (0.8–2.5) and 3.2% (1.7–4.7), 
respectively. One novel aspect of this study is that it 
was one of the first commercial noninferiority trials to 
evaluate a new pre- and post-milking teat disinfectant 
in a dairy herd with an automatic milking system. The 
experimental teat disinfectant ZkinCu, evaluated in 
this field trial with naturally occurring IMI, showed 
noninferiority relative to the positive control for the 
prevention of new IMI. This study was conducted in a 
herd with an automatic milking system, and the results 
are applicable to herds with similar characteristics. 
Additional studies are needed to ensure reproducibility 
under different management conditions.
Key words: noninferiority trial, teat disinfectant, 
intramammary infection, automatic milking
INTRODUCTION
Despite continued advances in prevention and treat-
ment over the past several decades, mastitis in dairy 
cows remains one of the leading causes of decreased 
milk production, lower milk quality, animal loss, and ul-
timately reduced profit for the dairy producer (Ruegg, 
2012). Pre- and post-milking disinfection of teats at 
each milking is a key recommended procedure for pre-
venting new IMI. A teat disinfectant must have several 
characteristics: germicidal efficacy; able to prevent new 
IMI; able to maintain teat condition; and leaves no resi-
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dues in milk that can affect human health. Although 
germicidal activity can be evaluated using in vitro tests 
(Boddie et al., 2002; Enger et al., 2015), these results 
cannot be extrapolated to effective mastitis control. 
Clinical trials evaluate the overall effect of teat disinfec-
tion in preventing new IMI (Fitzpatrick et al., 2018).
The product we evaluated in the present study com-
bines copper and zinc salts as active agents. Copper and 
zinc salts have shown excellent performance as biocides 
in many applications (Borkow and Gabbay, 2005; Var-
key, 2010). As well, these active ingredients contribute 
to skin health by accelerating the healing process and 
improving smoothness without percutaneous penetra-
tion (Hostynek and Maibach, 2006). Moreover, these 
elements are already present in milk, and they are es-
sential elements in the human diet (Uauy et al., 1998; 
Roohani et al., 2013).
Automatic milking is an alternative to conventional 
milking. Similar to other aspects of the automatic milk-
ing process, teat disinfection is performed by the robotic 
arm. To our knowledge, this is the first field study to 
evaluate the efficacy of teat disinfection in preventing 
natural occurring IMI in an automatic milking system. 
The aim of this study was to demonstrate the noninfe-
riority of a novel teat disinfectant based on copper and 
zinc (ZkinCu, ZC; Copper Andino, Santiago de Chile, 
Chile) compared with a previously proven disinfectant 
based on glycolic acid (OceanBlu, OB; DeLaval, Kan-
sas City, MO) as a positive control with respect to the 
incidence of new IMI that occurred under natural chal-
lenge conditions on a commercial robotic dairy farm.
MATERIALS AND METHODS
Study Farm and Study Pens
This noninferiority positive-control field study was 
conducted on a commercial robotic Holstein dairy farm 
in Chile. The herd was enrolled in a monthly testing 
program; herd average milk production, SCC, percent 
milk fat, and percent protein were 39 L/d, 178,000 
cells/mL, 3.9%, and 3.3%, respectively. Lactating cows 
are housed in freestall pens with reclaimed deep sand 
bedding. Alleyways are scraped continually. After calv-
ing, cows spend approximately 10 d in a fresh cow pen 
being milked in a conventional parlor, after which they 
are moved into robotic pens. This study was conducted 
in 6 robotic pens of approximately 60 milking cows 
each. We observed no differences between treatment 
groups in relation to SCC, DIM, parity, or milk pro-
duction (Table 1). The function of the DeLaval Classic 
robots (DeLaval Manufacturing, Kansas City, MO) was 
assessed periodically; settings remained according to 
the manufacturer’s recommendations.
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Cow Enrollment
The pens with OB disinfectant were paired with pens 
with ZC disinfectant that had the same characteristics 
for parity and DIM. Cows in a particular pen were ex-
posed to the same disinfectant throughout the study. 
After the initial treatment group assignment, new cows 
could be assigned to the study after 10 d postpartum. 
Cows diagnosed with clinical mastitis during the study 
were moved to a hospital pen after being registered. 
Cows that had clinical mastitis or were lame, dried off, 
or culled were withdrawn from the study. The studied 
pens included predominantly older cows, but also some 
animals in their first lactation.
Two weeks before study initiation, cows were exposed 
to the studied disinfectants. Application of the disin-
fectant 2 wk before the beginning of the study was re-
quired by the farmer to ensure that the product would 
not affect spray nozzles or teat skin condition.
Teat Disinfectant Identification
Throughout the 8-wk study, the same pre- and post-
milking teat disinfectant was used on each pen. In this 
robot model, one disinfectant is used both for dipping 
before and after milking. Cows in the OB group were 
treated with OceanBlu Pre-Post (DeLaval, Kansas City, 
MO), a pre- and post-milking disinfectant that used 
glycolic acid (3%) as the active ingredient, as well as 
other inactive ingredients in a proprietary blend called 
GlyTec (DeLaval Manufacturing). In the ZC pens, a 
novel zinc and copper disinfectant, ZkinCu (Copper 
Andino, Santiago de Chile, Chile), was used. The active 
ingredients in the formula were 10,600 mg/kg zinc ions 
from a mixture of zinc gluconate (65% by wt) and zinc 
sulfate monohydrate (35% by wt) and 10,600 mg/kg 
copper ions from a mixture of copper gluconate (20% by 
wt) and copper sulfate pentahydrate (80% by wt). The 
emollients were 5% glycerin, 5% sorbitol, and 1% pro-
pylene glycol. Polyvinyl alcohol was added to achieve a 
viscosity of 3 cP. The balance was demineralized water. 
The final pH was 6.1. The products were used from 
their original containers (60 L barrels) and were clearly 
marked to avoid misplacements. Study personnel were 
responsible for marking the barrels, controlling rate of 
usage, and monitoring blockage of the spray nozzles.
Training and Monitoring
A resident veterinarian monitored the study and 
was focused only on this trial. The veterinarian’s daily 
tasks included teat disinfectant coverage, teat condi-
tion scoring, and evaluation of animals suspected to 
have clinical mastitis [high mastitis detection index 
(MDi)]. The MDi is based on conductivity, milking 
interval, and blood detection, and is calculated using 
DelPro software (DeLaval International AB, Tumba, 
Sweden). The MDi is calculated at the cow level, not 
the quarter level, and provides a value on a scale of 1 
to 6 that indicates the likelihood of mastitis (Khatun et 
al., 2018). Cows with a high MDi (>1.4) were evaluated 
daily (forestrip) by the resident veterinarian for the 
presence of clinical mastitis. The threshold for visual 
detection was based on previously suggested optimal 
thresholds for distinguishing clinical from nonclinical 
quarters (Khatun et al., 2018).
Before the study began, personnel in charge of 
test-day sampling were trained in aseptic sampling 
techniques. We concluded that a 2-person team was 
needed per robot to perform the sampling of quarters 
every 2 wk. Clinical mastitis samples were cultured on 
farm with conventional techniques following National 
Mastitis Council procedures (Hogan et al., 1999). The 
study investigator, responsible for cultures, trained the 
farm laboratory personnel on culturing procedures. The 
resident veterinarian oversaw activities at sampling 
events every 2 wk. The study monitor visited the herd 
at monthly intervals. Tasks performed during visits 
included evaluation of management and application of 
the teat disinfectants (disinfectant barrel identification, 
product application procedures by the robotic arm); 
measurement and monitoring of product quantities; 
and reviewing record-keeping and on-farm laboratory 
procedures.
Application of Teat Disinfectants
The same milking procedures were used in all cows, 
and in each robot throughout the study. The teats were 
cleaned with a cleaning cup, which uses warm water, 
variable air pressure, and vacuum. Premilking hygiene 
consisted of applying disinfectant (OB or ZC, depend-
ing on the pen) by the robotic arm, spraying in a W 
pattern. The same product was applied to teats after 
milking, using the same pattern.
Milk Sample Collection, SCC Testing and Selection 
of Quarters for Bacterial Culture
The study was performed between July 10 and Sep-
tember 11, 2017. At the beginning of the study (wk 
0, baseline sample) and throughout the study period, 
all quarters of all study cows were sampled. Sampling 
was performed immediately before milking, using the 
following technique: after pre-milking disinfection had 
been performed by the robot, the robotic arm was 
stopped, the teat end was scrubbed with an alcohol 
scrub, 3 or 4 squirts of foremilk were discarded onto 
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the floor, and then 2 milk samples were collected. Milk 
samples collected for bacteriological culture were stored 
at −20°C until shipping.
At wk 2, 4, 6, and 8, composite milk samples were 
collected on farm for SCC determination using a 13-
mL vial containing a bronopol tablet. These samples 
were processed by the Biosur laboratory the day after 
the sampling visit, and SCC was determined using flow 
cytometry. The time lag between sampling and bacte-
riological culture did not exceed 1 wk.
Once composite SCC results were available, fro-
zen quarter samples from cows with composite SCC 
≥100,000 cells/mL were shipped for bacterial culture 
at the Bovine Mastitis Laboratory, Biochemistry and 
Microbiology Department, Faculty of Sciences, Uni-
versidad Austral de Chile (Valdivia, Chile). Staff who 
performed outcome assessments for SCC and milk bac-
teriology had no knowledge of treatment assignment.
Teat Condition Scoring
Teat barrel skin condition and degree of hyperkera-
tosis were evaluated at wk 0, 4, and 8 in a sample of 
cows. This evaluation was performed before the udder 
was prepared by the robot and before the milking unit 
was attached. Teat barrel skin condition was scored on 
a scale of 1 to 5 (1 = smooth, supple skin free from 
scales, cracks, or chapping; 2 = slight drying of skin 
with superficial flaking; 3 = more severe drying with 
early cracks present; 4 = more pronounced chapping 
and cracks in skin, along with redness indicating the 
presence of inflammation; and 5 = severe skin dam-
age with deep cracks, open ulcerative lesions, or scabs; 
Britt and Farnsworth, 1996). Hyperkeratosis of the teat 
orifice was also scored on a scale of 1 to 5 (1 = smooth 
teat end and sphincter with no evidence of roughness; 
2 = slight irregularities or fringes of roughness near 
orifice; 3 = teat end sphincter is moderately rough-
ened with radial cracks; 4 = teat orifice is significantly 
roughened with pronounced cracking; and 5 = teat end 
is severely roughened with deep irregular callous; Brit-
ten et al., 2004).
Microbiological Culture Standard  
Operating Procedures
Bacteriological analyses were carried out following 
accepted standards recommended by the National 
Mastitis Council (Hogan et al., 1999). A 0.01 mL ali-
quot from each milk sample was cultured on blood agar 
plates (Oxoid Diagnostic Reagents, Basingstoke, UK) 
containing 5% sheep blood cells. Plates were incubated 
at 37°C and examined for growth at 24 to 48 h. For 
plates with bacterial growth, the number of colonies 
was recorded for each species isolated, and colonies 
were subcultured on blood agar for further charac-
terization. Colony morphology, hemolysis pattern, 
and Gram stain results were described for each plate. 
Further characterization of gram-positive organisms 
involved catalase test reaction to differentiate between 
Staphylococcus and Streptococcus species, and followed 
up with coagulase testing. Organisms that were cata-
lase-positive/coagulase-negative were reported as CNS; 
catalase-positive/coagulase-positive organisms were 
reported as Staphylococcus aureus. Catalase-negative 
organisms had their identity confirmed by SVA Strep 
(SVA, Uppsala, Sweden). Gram-negative isolates were 
further tested using the API20 E identification system 
(bioMérieux SA, Marcy l’Étoile, France), which per-
mits rapid species identification of Enterobacteriaceae 
and other gram-negative organisms. Yeast was reported 
separately. If 3 or more different pathogens were pres-
ent in a sample, it was considered contaminated.
Definitions
Clinical mastitis was identified using MDi (Khatun 
et al., 2018) as a screening test. A veterinarian checked 
cows with an MDi ≥1.4 for the appearance of visibly 
abnormal milk (watery, flakes, or clots) to confirm the 
diagnosis. All clinical mastitis events for cows were 
recorded, and a milk sample was collected from the 
affected quarter using aseptic technique and frozen for 
later bacteriological culture.
Intramammary infection in biweekly quarter milk 
samples was determined using the following IMI defini-
tions from the quarter bacteriological culture result. An 
IMI was defined as 1 or more colonies isolated from 
a 0.01 mL milk sample for all pathogens except CNS 
and Bacillus spp. For CNS, 2 or more colonies isolated 
from a 0.01 mL milk sample were needed to establish 
presence of an IMI (Dohoo et al., 2011). For Bacillus 
spp., an IMI was defined as 5 or more colonies isolated 
from a 0.01-mL milk sample (Arruda et al., 2013). A 
single IMI was defined as the presence of only 1 type of 
pathogen in the sample; mixed infections were defined 
as the presence of 2 different bacterial species. A sample 
was considered contaminated if 3 or more bacterial spe-
cies were present. Clinical mastitis samples were also 
considered an IMI even if culture of the clinical milk 
sample produced no bacterial growth.
A new IMI was defined as a quarter in which the 
organism isolated was not present in the previous 
bacteriological sample or the previous composite SCC 
sample was <100,000 cells/mL. Clinical mastitis sam-
ples were also considered new IMI when supported by 
bacteriology tests.
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Statistical Analysis
The primary outcome considered was new IMI. The 
incidence of new IMI during the study period was calcu-
lated as the number of quarters with a new IMI divided 
by the amount of quarters at risk of a new IMI across 
all time points. A quarter at risk of a new IMI was 
defined as a quarter that was not infected or that had 
previous composite SCC <100,000 cells/mL. The study 
hypothesis was that we would find no differences in the 
incidence of IMI between the control and experimental 
pre- and post-milking teat dips in reducing naturally 
occurring infections. We used the difference in the pro-
portion of new IMI and 95% confidence intervals (CI) 
to evaluate noninferiority.
The trial was designed as a positive-control field 
trial, in which the objective was to show noninferiority 
of the new product (ZC) compared with the existing 
product used as a control (OB). If the difference be-
tween the control and the experimental product is zero 
or slightly in favor of the control, the products may still 
be considered equivalent (Schukken et al., 2013). The 
experimental disinfectant is considered inferior only 
when the difference is larger than a determined critical 
value (Schukken et al., 2013; Godden et al., 2016).
This critical value, called margin of noninferiority 
(d), was selected as the smallest value that would 
have a clinically important effect. We followed the ap-
proach described by Godden et al. (2016) to establish 
the d-value, using the same assumptions: 70% efficacy 
of control product, at least 40% of efficacy against a 
negative control of experimental product, and a ratio 
of less than 2 between the risk of infection with the 
experimental product and risk of infection with the 
positive control. The efficacy assumed for OB was 
at least 70% based on previous noninferiority studies 
(Godden et al., 2016; Lago et al., 2016). We therefore 
proposed the same noninferiority margin, used by God-
den et al. (2016): d = 0.035 (3.5%). We proposed this 
value based on the incidence of new IMI in a previous 
study (Hillerton et al., 2007) and because in the present 
study, the monthly incidence on the farm of new cases 
of subclinical mastitis using composite SCC from test 
day at a cut-off of 100,000 cells/mL showed values of 
2.5 to 4% in the preceding 3 mo.
Descriptive statistics were generated by treatment 
group and pen to describe baseline measures at wk 0, 
including parity, DIM, lnSCC, the prevalence of IMI 
(%), teat barrel skin condition scores, hyperkeratosis 
scores, and baseline bacteriology results. Descriptive 
statistics for new IMI by treatment group were gener-
ated for exploratory data analysis at the quarter level 
for each week of analysis (0, 2, 4, 6, and 8 wk). We cal-
culated the crude incidence of new IMI as the number 
of quarters that developed an IMI between successive 
biweekly sampling events divided by the number of 
quarters at risk for new IMI during that 2-wk interval. 
We calculated the crude prevalence of IMI during the 
study period as the number of IMI at a given time point 
divided by the number of quarters sampled at that time 
point.
The quarter was the unit of interest. The effect of 
treatment on quarter-level risk for new IMI for each 
2-wk sampling interval was modeled as a function of 
treatment group and other covariates using mixed lo-
gistic regression. The final mixed model was as follows:
 f(Yijk) = intcpt + β1 × treatment + βk × covariatesk   
+ week + treatment × week + cowj(random)  
+ quarteri(cowj)(random) + errorijk,
where f(Y) was the logit link function; Yijk was the 
occurrence of a new IMI (yes/no) in the quarteri; intcpt 
was the intercept; treatment was the variable indicating 
whether a quarter was in the ZC or OB group; and 
β1 referred to the regression coefficient for treatment. 
Other covariates (βk) investigated included quarter lo-
cation (A = right front, B = left front, C = right hind, 
D = left hind), lactation, and DIM. Time of sample col-
lection (wk 2, 4, 6, or 8) was forced as a fixed effect into 
the model. Cow was an indicator for cowj that we used 
as a random effect to model the within-cow correlation 
of quarters in the same cow. Quarteri(cowj) was used as 
a random effect to model the longitudinal correlation 
of observations within the same quarter. Error refers to 
the residual term in the model. An independent correla-
tion structure as used in all models.
Teat condition was compared using general linear 
mixed models to determine any difference by treatment 
and time. The teat condition score for barrel skin and 
hyperkeratosis were the response variables and time of 
teat evaluation (wk 0, 4, or 8) and treatment group 
were used as fixed effect in the model. Cow was used 
as a random effect to model the within-cow correlation 
of quarters in the same cow. Analyses were carried out 
using STATA (version 11; StataCorp, College Station, 
TX). The noninferiority analysis of the effect of treat-
ment with ZC on risk of new IMI was completed by 
calculating the new IMI proportion difference (95% CI) 
for ZC compared with OB, and then comparing the 
upper bound of the CI for the rate difference for ZC 
against the critical value.
RESULTS AND DISCUSSION
A total of 319 cows from 6 pens were enrolled in the 
study on July 10, and 157 and 162 cows were assigned 
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to the ZC and OB groups, respectively. The numbers of 
cows that finished the trial at wk 8 were 117 and 120 
in the ZC and OB group, respectively; 30 and 23 cows 
were added to the ZC and OB pens, respectively.
Each pen included an average of 53.2 milking cows 
[standard deviation (SD) = 2.4]. The pen average of 
DIM varied between 150.4 and 235.5 d, and the pen 
proportion of heifers varied between 20 and 46%. The 
mean (SD; range) parity and DIM for all cows at wk 0 
were 2.03 lactations (0.95; 1–5) and 199.42 d (109.94; 
39–662), respectively; we found no difference between 
the ZC and OB groups. The mean (SD; range) of lnSCC 
and the prevalence of IMI for all quarters at wk 0 were 
3.15 (1.42; 0–9.06) and 18.7%, respectively; we found 
no difference between the ZC and OB groups (Table 
1). Minor pathogens (Corynebacterium spp. and CNS) 
were the most prevalent in both ZC and OB group 
(Table 2). A total of 701 and 675 teat skin condition 
evaluations were performed at wk 0, 4, and 8 in the ZC 
and OB groups, respectively. The proportion of teats 
with normal teat barrel skin and hyperkeratosis degree 
(score = 1) was similar for the ZC and OB groups at 
the beginning of study (Table 1).
In this study, the farm design and robot model did 
not allow us to randomly assign cows to each treat-
ment group. As a result, assignment to treatment was 
paired, showing similar baseline characteristics between 
treatment groups and indicating that the differences 
between groups could be related to treatment. The dis-
infectant stayed the same in each robotic pen, and cows 
remained in the same robotic pen at every time point 
throughout the study. In addition, the robot used in 
the study applied the same disinfectant pre- and post-
Vissio et al.: TEAT DISINFECTANT IN AUTOMATIC MILKING SYSTEMS
Table 2. Baseline bacteriology results at enrollment (wk 0) for 
quarters assigned to the positive control (OceanBlu; DeLaval, Kansas 
City, MO) and experimental (ZkinCu; Copper Andino, Santiago de 
Chile, Chile) teat disinfectant treatment groups
Bacteriology results
Treatment group, no. (%)
ZkinCu OceanBlu
Samples cultured 609 (100) 617 (100)
Contaminated 4 (0.7) 15 (2.4)
Negative 495 (81.3) 502 (81.4)
Samples with growth 110 (18.1) 100 (16.2)
 Bacillus spp. 3 (0.5) 3 (0.5)
 Coliform 1 (0.2) 3 (0.5)
 Corynebacterium spp. 18 (3) 17 (2.8)
 Yeast 2 (0.3) —
 Pseudomonas spp. 1 (0.2) —
 CNS 68 (11.2) 68 (11)
 CNS–Corynebacterium spp. 3 (0.5) —
 Staphylococcus aureus 3 (0.5) 1 (0.2)
 Streptococcus dysgalactiae 4 (0.7) 2 (0.3)
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milking, so it was not possible to assess effectiveness 
separately.
The overall crude incidence of new IMI for a 2-wk 
period at risk was 4.9 and 7.3% for the ZC and OB 
groups, respectively (Table 3). The predominant or-
ganisms recovered from quarters with new IMI were 
Streptococcus uberis, Corynebacterium spp., and CNS 
in both the ZC and the OB groups (Table 4). The simi-
lar frequency of organisms isolated as the cause of new 
IMI in both treatment groups was expected, because 
all cows in the study herd were managed in the same 
way. The low frequency of major pathogens such as 
Staphylococcus aureus could be because the herd was 
relatively well managed in relation to udder health.
In the final mixed logistic regression model, only the 
variable treatment was significant; quarter location, 
DIM, and parity were not significant. The risk of infec-
tion in the OB group was higher (β = 0.644; 95% CI: 
0.05–1.22; P = 0.03). The interaction of treatment by 
week was not significant. Although week of sampling 
had no effect on risk for new IMI, we did force this vari-
able into the model. This lack of association may have 
been because no seasonal changes occurred during the 
study period. In relation to parity and quarter location, 
Godden et al. (2016) reported similar results in a trial 
with similar characteristics. The risk of IMI is greater 
at peak lactation (Zadoks et al., 2001; Olde Riekerink 
et al., 2007). In this study, few cows were evaluated 
at peak lactation, and this could explain the lack of 
association between DIM and new IMI.
The new IMI rate estimates (95% CI) for ZC and 
OB were 1.7% (0.8–2.5) and 3.2% (1.7–4.7), respec-
tively. The claim of noninferiority was made because 
the right-hand side of the 95% CI of the rate difference 
was smaller than the predefined noninferiority limit of 
d, defined a priori as 3.5% (or 0.035). The new IMI dif-
ferences (95% CI) for ZC were −1.5% (−3.2 to −0.2), 
because the upper bound of the CI for the rate differ-
ence was to the left of the critical value d (3.5%), so we 
can conclude that ZC was noninferior relative to OB 
with respect to risk for new IMI (Figure 1).
Initial teat barrel skin scores were not different for the 
ZC and OB treatment groups, did not change with time 
for either group, and were never significantly different 
(Table 5). Hyperkeratosis scores were significantly dif-
ferent between wk 0 and other weeks (P < 0.05), but 
we found no significant differences between ZC and OB 
for each week evaluated (Table 5).
One novel aspect of this study is that it was one of 
the first commercial noninferiority trials conducted to 
evaluate a new teat disinfectant in a dairy herd with 
an automatic milking system. We obtained these re-
sults using a 2-step diagnostic process: at each sample 
point, all composite milk samples were tested for SCC 
(screening test) and, on average, 26% of those cows 
were also tested using microbiological culture at the 
quarter level. The first step is screening at the cow level 
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Table 4. Etiology of new IMI acquired during the 8-wk study for 
quarters assigned to the positive control (OceanBlu; DeLaval, Kansas 
City, MO) and experimental (ZkinCu; Copper Andino, Santiago de 
Chile, Chile) teat disinfectant treatment groups
Item
Treatment group, no. (%)
ZkinCu OceanBlu
Quarters at risk of new IMI 2,028 1,982
Quarters with new IMI 99 (4.9) 144 (7.3)
Streptococcus uberis 7 (7.1) 15 (10.4)
Corynebacterium spp. 24 (24.2) 20 (13.9)
Streptococcus dysgalactiae 1 (1) 1 (0.7)
CNS 26 (26.3) 51 (35.4)
Clinical mastitis without bacterial growth 27 (27.3) 37 (25.7)
BnoF1 5 (5.1) 4 (2.8)
Yeast 2 (2) 8 (5.6)
Pseudomonas spp. 1 (1) —
CNS–Corynebacterium spp. 1 (1) —
Streptococcus uberis–Corynebacterium spp. 4 (4) —
Staphylococcus aureus 1 (1) 1 (0.7)
Bacillus spp. — 2 (1.4)
Coliforms — 2 (1.4)
Streptococcus agalactiae — 2 (1.4)
Streptococcus uberis–CNS — 1 (0.7)
1BnoF = gram-negative and nonfermentative rods.
Figure 1. Difference in new IMI rates between the ZkinCu (ZC; Copper Andino, Santiago de Chile, Chile) dip and the OceanBlu (OB; 
DeLaval, Kansas City, MO) dip in the noninferiority trial. The gray area indicates the zone of noninferiority. d = Δ, the critical value for de-
claring inferiority.
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to select animals with at least one quarter that may be 
infected. The SCC is a valuable screening tool, because 
it is quick and inexpensive. We used a cut-off of 100,000 
cells/mL, considering previous reports of composite 
SCC sensitivity (Vissio et al., 2014). High sensitivity 
values (85%) in low-prevalence situations (such as this 
herd) increase the negative predictive value of negative 
results and reduce the chance of false negatives. The 
second step was the determination of infection at the 
quarter level. Serial testing, as used in this study, maxi-
mizes the specificity and predictive value of a positive 
test result, but lowers sensitivity and negative predic-
tive value (Thrusfield, 2007). In this study, with a low 
incidence scenario, a strategy to optimize specificity 
would generally be recommended (Smith and Slenning, 
2000). A similar approach was used to evaluate pre-
milking teat disinfectant efficacy based on quarter SCC 
to screen, and the introduced bias due to diagnostic er-
ror was relatively small (Ceballos-Marquez et al., 2013). 
In the present study, the dilution effect of milk on SCC 
using composite samples could affect the sensitivity to 
detect IMI; to compensate for this lack of sensitivity, 
we used a low SCC threshold (100,000 cells/mL) for all 
cows. In this sense, when the threshold changes from 
200,000 to 100,000 cells/mL, the sensitivity increases 
by approximately 15% (Vissio et al., 2014).
A limitation of this study was our inability to 
evaluate the novel product (ZC) as post-milking teat 
disinfection only, because the robot applied the same 
disinfectant pre- and post-milking; this means that the 
results are not strictly comparable with the efficacy re-
ported in other studies. In addition, the positive control 
efficacy used in the present study was reported only 
for post-milking teat disinfection and not for pre and 
post-milking. Further studies are needed, using differ-
ent robot settings, to evaluate the disinfectant efficacy 
as a post-dip alone.
Another issue to consider was the application of the 
disinfectant 2 weeks before the beginning of our study. 
This practice was not reported previously in other tri-
als. In a similar study, cows were assigned to treatment 
after calving (Godden et al., 2016). Similarly, in the 
present study, cows that were enrolled after calving 
did not experience previous exposure to the products. 
On the other hand, the products were used for a short 
period of previous exposure (2 weeks) and had no 
therapeutic action. Therefore, the infection rate in the 
2 weeks before the beginning of the trial should not 
have been affected.
The present study was focused strictly on the evalu-
ation of ZC efficacy on the rate of IMI; because of this, 
it was not possible to evaluate the effect of ZC on robot 
structure and functionality. Further studies of longer 
duration and suitable design are needed to evaluate 
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issues such as corrosion, mineral deposit, soil, nozzle 
capping, and others.
CONCLUSIONS
The experimental teat disinfectant ZkinCu (Copper 
Andino), evaluated in this field trial with naturally oc-
curring IMI, showed noninferiority relative to the posi-
tive control for the prevention of new IMI. This study 
was conducted in a herd with an automatic milking 
system, and the results are applicable to herds with 
similar characteristics. Additional studies are needed 
to ensure reproducibility under different management 
conditions.
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